Q-Synovi logo

Powered by PQNS

NextGen Joint Health Solution

16 synergistic actives encapsulated in phospholipid nano-spheres for 85–90% uptake, >90% stability, and a gut-friendly profile.

Structural Support

  • Glucosamine + Chondroitin maintain cartilage matrix
  • Collagen peptides aid regeneration
  • Hyaluronic Acid lubricates joints

Anti-Inflammatory Action

  • Boswellia (AKBA) → 5-LOX modulation
  • Curcumin → NF-κB & COX-2 balance
  • PEA, Rosehip, Arnebia, Cissus for mobility

Antioxidant & Uptake

  • Moringa & Harad polyphenols protected
  • Omega-3 EPA/DHA stabilized
  • Piperine boosts curcumin absorption
0%
Target Bioavailability
0
Actives in Q-OsteoFlex™
0×
Multi-pathway Coverage

Mechanistic Highlights


  • Improved epithelial transport & endocytosis
  • Stabilized AKBA (Boswellia) & curcuminoids
  • Controlled release with phospholipid nano-spheres
  • Enhanced solubility and gut-friendly delivery

Osteoarthritis knee illustration
Inside the joint: cartilage wear, synovial changes, and debris drive pain & stiffness.

Understand Osteoarthritis—Then Target It Precisely

Clear visuals + plain language, mapped to how Q-Sinovi™ (powered by PQNS) supports joints across mechanisms.

Common osteoarthritis pain areas: hand/wrist, knee, hip, spine, shoulder, ankle
OA often affects hands, knees, hips, spine, shoulders, and ankles.

Where symptoms show up

  • Pain & stiffness during movement or after rest.
  • Swelling and warmth over the joint.
  • Grinding/crepitus from cartilage wear.
  • Reduced range of motion limiting daily activity.
Inside the knee showing osteophytes, eroded cartilage, cartilage debris, degenerative meniscus
Cartilage erosion, osteophytes (bone spurs), synovial changes, and debris.

Mechanism → Ingredient mapping

  • Cartilage wear: Glucosamine + Chondroitin; Denatured Collagen type II; HA.
  • Inflammatory mediators: Boswellia (AKBA→5-LOX), Cissus, Rosehip, Curcumin (NF-κB/COX-2).
  • Nociception & stiffness: PEA contributes to pain modulation and mobility.
  • Oxidative stress: Curcumin, Rose hip and Arnebia provide antioxidant defense.

PQNS shields actives from degradation and enhances epithelial transport.

Stages of knee osteoarthritis from early to severe
OA progression: joint-space narrowing and osteophyte growth over time.

What to expect by stage

Stage I–II (Early–Mild)

Great window for structure support + inflammation control.

Stage III (Moderate)

Multi-pathway relief: 5-LOX + NF-κB modulation, HA lubrication, collagen/UC-II tolerance.

Stage IV (Severe)

Symptom control remains helpful; discuss comprehensive care with a clinician.

Supplements complement, not replace, medical advice.

Clinical-Grade Formula

Synergistic triad: Structural • Anti-Inflammatory • Antioxidant + Uptake

Structural Support Glucosamine 100 mg • Chondroitin 100 mg • Collagen 50 mg • HA 50 mg

Cartilage matrix integrity, elasticity, regeneration, and synovial lubrication.

Anti-Inflammatory & Analgesia Boswellia 100 mg • Curcumin 90 mg • Rosehip 50 mg • PEA 75 mg • Arnebia 75 mg • Cissus 75 mg

5-LOX and NF-κB modulation; adjuncts for pain relief, stiffness reduction, and function.

Antioxidant & Cellular Defense Curcumin 90 mg • Rosehip 50 mg • Arnebia 75 mg • Omega-3 50 mg

Polyphenol-driven redox support and lipid mediators for tissue recovery.

Bioavailability & Supportive Factors Piperine 10 mg • Magnesium 75 mg • Vitamin D 400 IU

Enhanced curcuminoid uptake; bone/muscle integrity; calcium metabolism support.

How Q-Sinovi™ Compares

Standard Supplements

10–20% absorption, variable potency, higher doses, common GI irritation.

Q-Sinovi™ + PQNS

85–90% uptake, lower dosing with higher plasma levels, gut-friendly delivery.

Positioning:

Mild–moderate OA, athletes, and aging joints seeking multi-pathway relief and structural support.

Ready to Experience Q-Sinovi™?

Q-Synovi retail box

Clinically engineered multi-pathway therapeutic system for osteoarthritis.

Request Pricing